Skip to main content
. 2021 Apr 22;22(9):4361. doi: 10.3390/ijms22094361

Figure 3.

Figure 3

MCS upregulates the GSK3β/β-catenin signaling pathway and PI3K/AKT/mTOR/Fox01 signaling pathway. (A) Immunoblot analysis of the expression of p-GSK3β (Ser9), GSK3β, and β-catenin in HFDPC cells following treatment with MCS. (B) Immunoblot analysis of the expression of Wnt3a, p-AKT, AKT, p-ERK1/2, ERK1/2, p-p70S6K, p70S6K, p-Fox01, Fox01, p-mTOR, and mTOR in HFDPC cells following treatment with MCS. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 vs. control group; # p < 0.05, ## p < 0.01 vs. 25 μA MCS group.